PB1796: ADMINISTRATION OF A KETOGENIC DIET FOR CHEMOTHERAPY PROTECTION IN ACUTE LEUKEMIA PATIENTS: IS IT FEASIBLE, SAFE, AND VALUABLE? PRELIMINARY RESULTS OF THE RANDOMIZED CONTROLLED TRIAL LEU-KETO STUDY.
María Lastra Cagigas(The University of Sydney), Stephen J. Fuller(University of Reading), Luigi Fontana(Washington University in St. Louis), Gayathiri Rajakumar(The University of Sydney), Abolfazl Ardjmand(Kashan University of Medical Sciences), Kristen K. Skarratt(The University of Sydney), Rachael Hayward(The University of Sydney), Lachlin Vaughan(Westmead Hospital), Tiana Pelaia(The University of Sydney)
Cited by 2
Related Papers
Interventions to Slow Aging in Humans: Are We Ready?
|Aging Cell|2015|598
Decreased Consumption of Branched-Chain Amino Acids Improves Metabolic Health
|Cell Reports|2016|476
Risk of cardiovascular disease morbidity and mortality in frail and pre-frail older adults: Results from a meta-analysis and exploratory meta-regression analysis
|Ageing Research Reviews|2017|299